| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6246932 | Transplantation Proceedings | 2016 | 5 Pages |
Abstract
After 5 years of establishing the first dedicated ITx program in Australia and New Zealand, early results indicate that ITx is an available and life-saving option for IF patients in these countries. Current barriers to ITx in Australia include a shortage of appropriate donors and a high rate of donor-specific antibodies among potential recipients. Growing awareness of the service and early referral to assist appropriate patient selection will aid in the program's success.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
B. Chapman, P. De Cruz, R. Jones, W. Hardikar, A. Testro,